New trials, publications, preprints and grants on this target, month by month.
Trial
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
1 Jan 2027· PHASE4 · NOT_YET_RECRUITING· CTGOV
Publication
Critical comparison of ELISA kits for CGRP measurements in migraine.
5 Nov 2026· Headache· PUBMED
Publication
CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker.
3 Nov 2026· Biomarkers in medicine· PUBMED
Publication
Real-World Effectiveness and Utilisation of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in a Public Healthcare System.
3 Nov 2026· Drugs - real world outcomes· PUBMED
Publication
The role of neurogenic inflammation and CGRP in migraine headache.
2 Nov 2026· British journal of pharmacology· PUBMED
Publication
[CGRP-targeted drugs in chronic migraine prophylaxis: comparing efficacy and tolerability.].
1 Nov 2026· Recenti progressi in medicina· PUBMED
Publication
Development of a machine learning (ML) model to predict 3-month response to CGRP monoclonal antibodies in migraine: A pilot evaluation of physician-ML model interaction.
28 Oct 2026· Headache· PUBMED
Publication
Longitudinal effects of CGRP-targeting migraine therapies on blood pressure and body mass index: A 12-month retrospective analysis.
25 Oct 2026· Headache· PUBMED
Publication
Sensory neuron-derived CGRP ameliorates kidney injury and fibrosis via monocytes and macrophages.
23 Oct 2026· Cell research· PUBMED
Publication
A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine.
20 Oct 2026· CNS & neurological disorders drug targets· PUBMED
Publication
Changes in plasma CGRP levels and clinical outcomes following acupuncture in episodic migraine: a prospective pilot study (the AcuCGRP study).
16 Oct 2026· Frontiers in neurology· PUBMED
Publication
CGRP-RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression.
14 Oct 2026· International journal of molecular sciences· PUBMED
Trial
Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations
12 Oct 2026· NA · ACTIVE_NOT_RECRUITING· CTGOV
Publication
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk.
12 Oct 2026· JAMA neurology· PUBMED
Publication
Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.
9 Oct 2026· Epilepsia open· PUBMED
Publication
Same trials, different answers: reconciling four meta-analyses of anti-CGRP antibodies in cluster headache.
9 Oct 2026· Pain management· PUBMED
Publication
Bushen Huoxue Formula promotes osteoporotic fracture healing by CGRP-mediated dual regulation of BMSCs-osteoclasts balance through modulating mitochondrial energy metabolism.
7 Oct 2026· Phytomedicine : international journal of phytotherapy and phytopharmacology· PUBMED
Trial
Psychological Support for Chronic Migraine Patients Treated With Anti-CGRP (Anti-Calcitonin Gene-Related Peptide ) Monoclonal Antibodies
1 Oct 2026· NA · NOT_YET_RECRUITING· CTGOV
Trial
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
1 Oct 2026· PHASE2 · NOT_YET_RECRUITING· CTGOV
Publication
CGRP remodels the acidic microenvironment and promotes pancreatic carcinoma progression by regulating NHE1 and CA9.
1 Oct 2026· Frontiers in pharmacology· PUBMED
Publication
Calcitonin Gene-Related Peptide (CGRP) in Bone Repair and Musculoskeletal Pain: A Scoping Review of Skeletal Regeneration, Joint and Tendon Involvement, and CGRP-Targeted Therapies.
1 Oct 2026· Calcified tissue international· PUBMED
Trial
Tear Biomarkers for Migraine
30 Sept 2026· NA · NOT_YET_RECRUITING· CTGOV
Publication
Persistence and Reasons for Treatment Discontinuation of Anti-CGRP Therapies in Migraine Prophylaxis: A Systematic Review and Meta-analysis of Real-World Studies.
30 Sept 2026· Pain and therapy· PUBMED
Publication
Guest editorial on "Anti-CGRP treatments in women's health: Gaps and clinical evidence in menstrual migraine, pregnancy, lactation, and hormonal contraception".
29 Sept 2026· Headache· PUBMED
Publication
Tear fluid CGRP changes in epilepsy - evidence from an exploratory pilot study.
23 Sept 2026· Seizure· PUBMED
Publication
The CGRP-nociceptor axis in cancer: tumor-specific programs of immune evasion, stromal remodeling, and tumor growth.
22 Sept 2026· Frontiers in oncology· PUBMED
Publication
Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A Multicenter Retrospective Observational Study.
20 Sept 2026· Biomedicines· PUBMED
Trial
Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine
17 Sept 2026· NA · NOT_YET_RECRUITING· CTGOV
Publication
Resistance training for migraine in females: mechanistic review of hormonal, CGRP, autonomic, vascular, and nociceptive pathways.
17 Sept 2026· Journal of neurophysiology· PUBMED
Publication
Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease.
15 Sept 2026· Journal of neurology· PUBMED